ALENDA BHB
Natural health product licensed in Canada
- Other names
- ALENDA BHB 5.4 g, ALENDA BHB 5400 mg, Alenda BHB Salts, Alenda Ultra BHB, BHB Salts, Beta-hydroxybutyrate (BHB), Premium BHB, Premium BHB 5400 mg, Premium goBHB, Ultra BHB, Ultra BHB 5400 mg, Ultra Premium BHB, Ultra goBHB 5.4 g
- Licence holder
- Alenda Corp.
- NPN or DIN-HM
- 80111316
- Status
- Active licence
- Licence date
- 12 July 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Silice, Cellulose, Stéarate de magnésium, Gélatine, Hydroxypropyl méthylcellulose, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides/source of beta-hydroxybutyrate that helps in/supports/contributes to energy production in the body.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80111316
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.